Noven Pharmaceuticals
Overview
Noven Pharmaceuticals is a pharmaceutical company headquartered in Miami, United States, founded in 1987, with 201-500 employees.
FDA compliance signals
50 FDA enforcement records linked to this company.
- recall — Class II2024-11-27
Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).
- recall — Class II2023-03-29
Defective Delivery System: Out of specification for shear.
- recall — Class II2023-03-29
Defective Delivery System: Out of specification for shear.
- recall — Class II2023-03-29
Defective Delivery System: Out of specification for shear.
- recall — Class II2023-03-29
Defective Delivery System: Out of specification for shear.
- recall — Class II2022-12-07
Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.
- recall — Class II2022-07-06
Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.
- recall — Class II2022-06-01
Defective Delivery System: customer complaints exceeded respective action limits.
- recall — Class II2021-08-25
Failed Stability Specifications; out of specification for shear.
- recall — Class II2021-08-25
Failed Stability Specifications; out of specification for shear.
- recall — Class II2021-06-02
Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.
- recall — Class II2021-06-02
Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.
- recall — Class II2021-04-28
Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.
- recall — Class II2021-04-28
Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.
- recall — Class II2021-03-10
Defective Delivery System: Out of specification for mechanical peel.
Is this Noven Pharmaceuticals? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.